BACKGROUND Transmission of the proposal to the Council and to the European Parliament - COM(2004) 599 final â€“ 2004/0217 (COD) | 22 October 2004 | Opinion of the Economic and Social Committee | 11 May 2005 | Opinion of the European Parliament - first reading | 7 September 2005 | Transmission of the amended proposal to the Council - COM(2005) 577 | 10 November 2005 | Adoption of the Council common position by qualified majority | 10 March 2006 | Opinion of the European Parliament - second reading | 1 June 2006 | 2.
ANNEX Declaration by the Commission: "In view of the risks of carcinogens, mutagens and substances toxic to reproduction, the Commission will request the Committee for Medicinal Products for Human Use of the European Medicines Agency to draw up an opinion on the use of these categories of substances as excipients of medicinal products for human use, on the basis of Articles 5(3) and 57(1)(p) of Regulation (EC) No 726/2004 of 31 March 2004, laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency.
